标题
Epilepsy in Dravet Syndrome—Current and Future Therapeutic Opportunities
作者
关键词
-
出版物
Journal of Clinical Medicine
Volume 12, Issue 7, Pages 2532
出版商
MDPI AG
发表日期
2023-03-28
DOI
10.3390/jcm12072532
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pharmacokinetics, pharmacodynamics and safety assessment of multiple doses of soticlestat in healthy volunteers
- (2022) Shining Wang et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Development and Validation of a Prediction Model for Early Diagnosis of SCN1A-Related Epilepsies
- (2022) Andreas Brunklaus et al. NEUROLOGY
- International consensus on diagnosis and management of Dravet syndrome
- (2022) Elaine C. Wirrell et al. EPILEPSIA
- COVID‐19 vaccine in patients with Dravet syndrome: Observations and real‐world experiences
- (2022) Veronica Hood et al. EPILEPSIA
- Cell-selective AAV-mediated <i>SCN1A </i>Gene Regulation Therapy Rescues Mortality and Seizure Phenotypes in a Dravet Syndrome Mouse Model and is Well Tolerated in Non-human Primates
- (2022) Annie Tanenhaus et al. HUMAN GENE THERAPY
- A phase 2, randomized, double‐blind, placebo‐controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in pediatric patients with Dravet syndrome or Lennox–Gastaut syndrome ( ELEKTRA )
- (2022) Cecil D. Hahn et al. EPILEPSIA
- Intravenous ganaxolone for the treatment of refractory status epilepticus: Results from an open‐label , dose‐finding , phase 2 trial
- (2022) Henrikas Vaitkevicius et al. EPILEPSIA
- Safety, tolerability, pharmacokinetics, pharmacodynamics, bioavailability and food effect of single doses of soticlestat in healthy subjects
- (2021) Shining Wang et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Stiripentol in the treatment of adults with focal epilepsy- a retrospective analysis
- (2021) L. Habermehl et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Results From an Italian Expanded Access Program on Cannabidiol Treatment in Highly Refractory Dravet Syndrome and Lennox–Gastaut Syndrome
- (2021) Luigi Francesco Iannone et al. Frontiers in Neurology
- Add‐on cannabidiol in patients with Dravet syndrome: Results of a long‐term open‐label extension trial
- (2021) Ingrid E. Scheffer et al. EPILEPSIA
- Efficacy, tolerability, and retention of fenfluramine for the treatment of seizures in patients with Dravet syndrome: Compassionate use program in Germany
- (2021) Adam Strzelczyk et al. EPILEPSIA
- Soticlestat, a novel cholesterol 24‐hydroxylase inhibitor, reduces seizures and premature death in Dravet syndrome mice
- (2021) Nicole A. Hawkins et al. EPILEPSIA
- Transfer of SCN1A to the brain of adolescent mouse model of Dravet syndrome improves epileptic, motor, and behavioral manifestations
- (2021) Lucia Mora-Jimenez et al. Molecular Therapy-Nucleic Acids
- Fenfluramine significantly reduces day‐to‐day seizure burden by increasing number of seizure‐free days and time between seizures in patients with Dravet syndrome: A time‐to‐event analysis
- (2021) Joseph Sullivan et al. EPILEPSIA
- The impact of SARS-CoV-2 vaccination in Dravet syndrome: A UK survey
- (2021) Lisa M. Clayton et al. EPILEPSY & BEHAVIOR
- Preclinical characterization of [18F]T-008, a novel PET imaging radioligand for cholesterol 24-hydroxylase
- (2021) Tatsuki Koike et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Scn8a Antisense Oligonucleotide Is Protective in Mouse Models of SCN8A Encephalopathy and Dravet Syndrome
- (2020) Guy M. Lenk et al. ANNALS OF NEUROLOGY
- Dravet syndrome: Treatment options and management of prolonged seizures
- (2020) J. Helen Cross et al. EPILEPSIA
- Dravet Syndrome: A Review of Current Management
- (2020) James W. Wheless et al. PEDIATRIC NEUROLOGY
- Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome
- (2020) Ian Miller et al. JAMA Neurology
- Antisense oligonucleotide modulation of non-productive alternative splicing upregulates gene expression
- (2020) Kian Huat Lim et al. Nature Communications
- Efficacy and safety of Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: A real‐world study
- (2020) Nicola Specchio et al. EPILEPSIA
- Antisense oligonucleotides increase Scn1a expression and reduce seizures and SUDEP incidence in a mouse model of Dravet syndrome
- (2020) Zhou Han et al. Science Translational Medicine
- Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice
- (2020) Toshiya Nishi et al. Scientific Reports
- Long-term safety and effectiveness of stiripentol in patients with Dravet syndrome: Interim report of a post-marketing surveillance study in Japan
- (2020) Miyuki Yamada et al. EPILEPSY RESEARCH
- Stiripentol for the treatment of seizures associated with Dravet syndrome
- (2019) Catherine Chiron Expert Review of Neurotherapeutics
- Long-term safety and efficacy of cannabidiol in children and adults with treatment-resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results
- (2019) Linda C. Laux et al. EPILEPSY RESEARCH
- Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort
- (2019) Joseph D Symonds et al. BRAIN
- Inhaled alprazolam rapidly suppresses epileptic activity in photosensitive participants
- (2019) Jacqueline A. French et al. EPILEPSIA
- dCas9-based Scn1a gene activation restores inhibitory interneuron excitability and attenuates seizures in Dravet syndrome mice
- (2019) Gaia Colasante et al. MOLECULAR THERAPY
- Lorcaserin: A review of its preclinical and clinical pharmacology and therapeutic potential
- (2019) Guy A. Higgins et al. PHARMACOLOGY & THERAPEUTICS
- Sexually Divergent Mortality and Partial Phenotypic Rescue After Gene Therapy in a Mouse Model of Dravet Syndrome
- (2019) Yosuke Niibori et al. HUMAN GENE THERAPY
- Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial
- (2019) Lieven Lagae et al. LANCET
- Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens
- (2019) Rima Nabbout et al. JAMA Neurology
- Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A -related seizure phenotypes
- (2018) Iris M. de Lange et al. EPILEPSIA
- Lorcaserin therapy for severe epilepsy of childhood onset
- (2018) Patricia Tolete et al. NEUROLOGY
- Cognitive outcomes following epilepsy in infancy: A longitudinal community-based study
- (2018) Helen O'Reilly et al. EPILEPSIA
- Dravet syndrome and its mimics: Beyond SCN1A
- (2017) Dora Steel et al. EPILEPSIA
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Optimizing the Diagnosis and Management of Dravet Syndrome: Recommendations From a North American Consensus Panel
- (2017) Elaine C. Wirrell et al. PEDIATRIC NEUROLOGY
- From genotype to phenotype in Dravet disease
- (2017) Svetlana Gataullina et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Pharmacological Analysis of the Anti-epileptic Mechanisms of Fenfluramine in scn1a Mutant Zebrafish
- (2017) Jo Sourbron et al. Frontiers in Pharmacology
- Audit of use of stiripentol in adults with Dravet syndrome
- (2016) S. Balestrini et al. ACTA NEUROLOGICA SCANDINAVICA
- Mortality in Dravet syndrome: A review
- (2016) Sharon Shmuely et al. EPILEPSY & BEHAVIOR
- Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
- (2016) Orrin Devinsky et al. LANCET NEUROLOGY
- The incidence ofSCN1A-related Dravet syndrome in Denmark is 1:22,000: A population-based study from 2004 to 2009
- (2015) Allan Bayat et al. EPILEPSIA
- Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy
- (2015) Alexandra L. Geffrey et al. EPILEPSIA
- Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan
- (2015) Yushi Inoue et al. EPILEPSY RESEARCH
- Incidence of Dravet Syndrome in a US Population
- (2015) Y. W. Wu et al. PEDIATRICS
- Carbamazepine and oxcarbazepine in adult patients with Dravet syndrome: Friend or foe?
- (2015) F.M. Snoeijen-Schouwenaars et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Pharmacological Characterization of an Antisense Knockdown Zebrafish Model of Dravet Syndrome: Inhibition of Epileptic Seizures by the Serotonin Agonist Fenfluramine
- (2015) Yifan Zhang et al. PLoS One
- Long-term course of Dravet syndrome: A study from an epilepsy center in Japan
- (2014) Rumiko Takayama et al. EPILEPSIA
- Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome
- (2012) A. Brunklaus et al. BRAIN
- Novel SCN1A Mutation in a Proband With Malignant Migrating Partial Seizures of Infancy
- (2011) Emily R. Freilich et al. ARCHIVES OF NEUROLOGY
- Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology
- (2011) C. B. Catarino et al. BRAIN
- Overall management of patients with Dravet syndrome
- (2011) BERTEN CEULEMANS DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- A retrospective study of the relation between vaccination and occurrence of seizures in Dravet syndrome
- (2011) Blanca Tro-Baumann et al. EPILEPSIA
- Dravet syndrome: The long-term outcome
- (2011) Pierre Genton et al. EPILEPSIA
- The core Dravet syndrome phenotype
- (2011) Charlotte Dravet EPILEPSIA
- Low long-term efficacy and tolerability of add-on rufinamide in patients with Dravet syndrome
- (2011) A. Mueller et al. EPILEPSY & BEHAVIOR
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now